These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 19047910)

  • 21. [Prognostic significance of cellular DNA content and AgNOR count in ovarian cystadenoma].
    Lu XL; Yi WM; Wang LF
    Ai Zheng; 2003 Jan; 22(1):62-5. PubMed ID: 12561439
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The prognostic and predictive value of syntactic structure analysis in serous carcinoma of the ovary.
    Palmer JE; Sant Cassia LJ; Irwin CJ; Morris AG; Janssen EA; Baak JP; Rollason TP
    Int J Gynecol Pathol; 2008 Apr; 27(2):191-8. PubMed ID: 18317224
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Prognostic significance of tumor cell ploidy in advanced ovarian carcinoma].
    Novik VI; Gevorkian VA; Maksimov SIa
    Vopr Onkol; 2006; 52(1):54-8. PubMed ID: 16715704
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prognosis and management of borderline tumours of the ovary.
    Tropé C; Kaern J
    Curr Opin Obstet Gynecol; 1996 Feb; 8(1):12-6. PubMed ID: 8777251
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Different clinical roles for p21-activated kinase-1 in primary and recurrent ovarian carcinoma.
    Davidson B; Shih IeM; Wang TL
    Hum Pathol; 2008 Nov; 39(11):1630-6. PubMed ID: 18656238
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prognostic factors predicting recurrence in borderline ovarian tumors.
    Wu TI; Lee CL; Wu MY; Hsueh S; Huang KG; Yeh CJ; Lai CH
    Gynecol Oncol; 2009 Aug; 114(2):237-41. PubMed ID: 19481786
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Flow cytometry as a prognostic indicator in women with borderline epithelial ovarian tumors.
    Harlow BL; Fuhr JE; McDonald TW; Schwartz SM; Beuerlein FJ; Weiss NS
    Gynecol Oncol; 1993 Sep; 50(3):305-9. PubMed ID: 8406192
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation of genomic changes in a large series of malignant ovarian germ cell tumors--relation to clinicopathologic variables.
    Kildal W; Kaern J; Kraggerud SM; Abeler VM; Sudbø J; Tropè CG; Lothe RA; Danielsen HE
    Cancer Genet Cytogenet; 2004 Nov; 155(1):25-32. PubMed ID: 15527899
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Frequent microsatellite instability in epithelial borderline ovarian tumors.
    Tangir J; Loughridge NS; Berkowitz RS; Muto MG; Bell DA; Welch WR; Mok SC
    Cancer Res; 1996 Jun; 56(11):2501-5. PubMed ID: 8653685
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Long-term outcome and prognostic factors for yolk sac tumor of the ovary.
    Umezu T; Kajiyama H; Terauchi M; Shibata K; Ino K; Nawa A; Kikkawa F
    Nagoya J Med Sci; 2008 Mar; 70(1-2):29-34. PubMed ID: 18807293
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prognostic significance of DNA content and nuclear morphology in borderline ovarian tumors.
    Drescher CW; Flint A; Hopkins MP; Roberts JA
    Gynecol Oncol; 1993 Feb; 48(2):242-6. PubMed ID: 8428698
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Expression of DNA damage checkpoint protein Hus1 in epithelial ovarian tumors correlates with prognostic markers.
    de la Torre J; Gil-Moreno A; García A; Rojo F; Xercavins J; Salido E; Freire R
    Int J Gynecol Pathol; 2008 Jan; 27(1):24-32. PubMed ID: 18156970
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Do bone marrow isolated tumor cells influence long-term survival of non-small cell lung cancer?
    Ruffato A; Mattioli S; Pileri S; Daddi N; D'Ovidio F; Pilotti V; Tazzari P
    Eur J Cardiothorac Surg; 2009 Mar; 35(3):463-8. PubMed ID: 19150243
    [TBL] [Abstract][Full Text] [Related]  

  • 34. GSTP1-1 in ovarian cyst fluid and disease outcome of patients with ovarian cancer.
    Kolwijck E; Zusterzeel PL; Roelofs HM; Hendriks JC; Peters WH; Massuger LF
    Cancer Epidemiol Biomarkers Prev; 2009 Aug; 18(8):2176-81. PubMed ID: 19661073
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Proliferating cell nuclear antigen (PCNA) and Ki-67 in epithelial ovarian tumours: correlation with DNA flow cytometric analysis.
    Karaburun S; Karaveli S; Peştereli HE; Simsek T; Sargin CF
    Adv Clin Path; 2001 Jan; 5(1-2):3-9. PubMed ID: 11753828
    [TBL] [Abstract][Full Text] [Related]  

  • 36. VEGF-A and i-NOS expression are prognostic factors in serous epithelial ovarian carcinomas after complete surgical resection.
    Engels K; du Bois A; Harter P; Fisseler-Eckhoff A; Kommoss F; Stauber R; Kaufmann M; Nekljudova V; Loibl S
    J Clin Pathol; 2009 May; 62(5):448-54. PubMed ID: 19126566
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prognostic factors in adult granulosa cell tumor of the ovary.
    Li W; Wu X; Fang C; Yao J; Guo Y; Zhang S
    Saudi Med J; 2009 Feb; 30(2):247-52. PubMed ID: 19198715
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Histologic classification and morphologic prognostic factors in malignant ovarian tumors].
    Horn LC; Fricke K; Krugmann J
    Zentralbl Gynakol; 1995; 117(7):335-45. PubMed ID: 7668062
    [TBL] [Abstract][Full Text] [Related]  

  • 39. DNA flow cytometry, clinical and morphological parameters as prognostic factors for advanced malignant and borderline ovarian tumors.
    Kühn W; Kaufmann M; Feichter GE; Rummel HH; Schmid H; Heberling D
    Gynecol Oncol; 1989 Jun; 33(3):360-7. PubMed ID: 2722063
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical and pathological predictive factors in women with adult-type granulosa cell tumor of the ovary.
    Villella J; Herrmann FR; Kaul S; Lele S; Marchetti D; Natiella J; Odunsi K; Mhawech-Fauceglia P
    Int J Gynecol Pathol; 2007 Apr; 26(2):154-9. PubMed ID: 17413982
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.